logo
Send Message

Small Molecule Antiviral Drug Molnupiravir New Therapeutic Option For Relapsed FIP Cats

50 grams
MOQ
Negotiable
Price
Small Molecule Antiviral Drug Molnupiravir New Therapeutic Option For Relapsed FIP Cats
Features Gallery Product Description Request A Quote
Features
Specifications
Indication: Treatment Of COVID-19
COA: Available
CAS: 2349386-89-4
Shelf Life: 2 Year
Shipping Method: Air(UPS, FedEx, TNT, EMS) Or Sea
Purity: 99%
Molecular Formula: C13H19N3O7
Grade: Pharmaceutcial Grade
Deliver Time: 5-10 Days
Specification: 1kg/bag 25kg/drum
Origin: China
Highlight:

Molnupiravir small molecule antiviral drug

,

Relapsed FIP Cats Molnupiravir

,

Therapeutic Option Molnupiravir

Basic Infomation
Place of Origin: China
Payment & Shipping Terms
Packaging Details: Plastic Bag Inside, Aluminum Foil Bag Outside
Delivery Time: 2-3 days
Payment Terms: D/A, D/P, L/C, T/T, Western Union, MoneyGram
Supply Ability: 100,000 kg per month
Product Description

Product Description:

 

Molnupiravir is a small molecule antiviral drug with a chemical structure that enables it to interfere with the replication process of RNA viruses. It is a prodrug, meaning it is metabolized in the body into its active form, which then exerts its antiviral effects.

 

The primary mechanism of action of Molnupiravir involves inhibiting viral replication by inducing lethal mutations in the genetic material of the virus. Once metabolized into its active form, Molnupiravir mimics one of the building blocks of RNA. When the virus attempts to replicate its genetic material using Molnupiravir, it introduces errors into its RNA sequence, leading to nonviable or less infectious viral progeny. This disruption of viral replication ultimately hampers the virus's ability to spread and cause infection.

 

Molnupiravir, while showing promise as an antiviral drug for treating various viral infections in humans, has not been extensively studied or approved for use in veterinary medicine, including for the treatment of Feline Infectious Peritonitis (FIP). FIP is a complex and often fatal viral disease in cats caused by certain strains of feline coronavirus.

 

Technical Parameters:

 

Technical Parameter Value
Generic Name EIDD-2801 (2349386-89-4)
Indication Treatment of COVID-19 (Cat FIP Treatment)
Country of Origin China
Shipping Method Air (UPS, FedEx, TNT, EMS) or Sea
Shelf Life 2 years
Purity 99%
CAS 2349386-89-4
COA Available
Molecular Weight 329.31 g/mol

 

Function:

 

Molnupiravir gained significant attention during the COVID-19 pandemic as a potential oral antiviral treatment for SARS-CoV-2, the virus that causes COVID-19. Clinical trials have been conducted to evaluate its efficacy and safety in COVID-19 patients.

 

Studies have shown that Molnupiravir can reduce the duration of viral shedding and symptoms in COVID-19 patients when administered early in the course of the infection. It is believed to help limit the spread of the virus within the body and potentially reduce the severity of the illness.

Packing and Shipping:

 

1~25kgs packaging: Aluminium bag inside, Carton box outside.


25kgs packaging: Plastic bag inside, Fiber drum outside

 

Small Molecule Antiviral Drug Molnupiravir New Therapeutic Option For Relapsed FIP Cats 0
Recommended Products
Get in touch with us
Contact Person : Nancylee
Tel : +86 15508667508
Characters Remaining(20/3000)